Effect of latanoprost on outflow facility in the mouse
- PMID: 15223801
- DOI: 10.1167/iovs.03-0990
Effect of latanoprost on outflow facility in the mouse
Abstract
Purpose: To assess the early effect of latanoprost on outflow facility and aqueous humor dynamics in the mouse.
Methods: Aqueous humor dynamics in NIH Swiss White mice were assessed with an injection and aspiration system, using fine glass microneedles. A single 200-ng (4 microL) dose of latanoprost was applied to one eye 2 hours before measurement. The fellow eye served as a control. Intraocular pressure (IOP) was measured by using an established microneedle procedure. Outflow facility (C) was determined by constant-pressure perfusion measurements obtained at two different IOPs. Aqueous humor flow (Fa) was determined by a dilution method using rhodamine-dextran. Conventional and uveoscleral outflow (Fc and Fu) were calculated by the Goldmann equation.
Results: Average IOP, Fa, and C of control eyes were 15.7 +/- 1.0 mm Hg, 0.144 +/- 0.04 microL/min (mean +/- SD, n = 8), and 0.0053 +/- 0.0014 microL/min per mm Hg (n = 21), respectively. Average IOP, Fa, and C of treated eyes were 14.0 +/- 0.8 mm Hg, 0.138 +/- 0.04 microL/min (n = 8 for each), and 0.0074 +/- 0.0016 microL/min per mm Hg (n = 21), respectively. The differences between treated and control eyes were significant for IOP and total outflow facility only.
Conclusions: These data indicate that the early hypotensive effect of latanoprost in the mouse eye is associated with a significant increase in total outflow facility. Alterations in the aqueous dynamics induced by latanoprost can be measured reproducibly in the mouse and may provide a useful model for further determining the mechanism by which latanoprost reduces IOP and alters outflow facility.
Similar articles
-
Assessment of aqueous humor dynamics in the mouse by a novel method of constant-flow infusion.Invest Ophthalmol Vis Sci. 2011 Feb 3;52(2):685-94. doi: 10.1167/iovs.10-6069. Invest Ophthalmol Vis Sci. 2011. PMID: 20861483
-
Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4143-7. doi: 10.1167/iovs.07-0035. Invest Ophthalmol Vis Sci. 2007. PMID: 17724199
-
Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment.J Glaucoma. 2010 Aug;19(6):356-64. doi: 10.1097/IJG.0b013e3181d12dd8. J Glaucoma. 2010. PMID: 20179619 Clinical Trial.
-
[Pharmacological profiles of latanoprost (Xalatan), a novel anti-glaucoma drug].Nihon Yakurigaku Zasshi. 2000 May;115(5):280-6. doi: 10.1254/fpj.115.280. Nihon Yakurigaku Zasshi. 2000. PMID: 10872179 Review. Japanese.
-
Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function.Surv Ophthalmol. 1997 Feb;41 Suppl 2:S69-75. doi: 10.1016/s0039-6257(97)80010-0. Surv Ophthalmol. 1997. PMID: 9154279 Review.
Cited by
-
Effect of prostaglandin analogues on anterior scleral thickness and corneal thickness in patients with primary open-angle glaucoma.Sci Rep. 2021 May 27;11(1):11098. doi: 10.1038/s41598-021-90696-4. Sci Rep. 2021. PMID: 34045600 Free PMC article.
-
The IOP-lowering effects and mechanism of action of tafluprost in prostanoid receptor-deficient mice.Br J Ophthalmol. 2007 May;91(5):673-6. doi: 10.1136/bjo.2006.105585. Epub 2006 Nov 23. Br J Ophthalmol. 2007. PMID: 17124244 Free PMC article.
-
Impaired angiopoietin/Tie2 signaling compromises Schlemm's canal integrity and induces glaucoma.J Clin Invest. 2017 Oct 2;127(10):3877-3896. doi: 10.1172/JCI94668. Epub 2017 Sep 18. J Clin Invest. 2017. PMID: 28920924 Free PMC article.
-
Measurement of Outflow Facility Using iPerfusion.PLoS One. 2016 Mar 7;11(3):e0150694. doi: 10.1371/journal.pone.0150694. eCollection 2016. PLoS One. 2016. PMID: 26949939 Free PMC article.
-
Model systems for the study of steroid-induced IOP elevation.Exp Eye Res. 2017 May;158:51-58. doi: 10.1016/j.exer.2016.07.013. Epub 2016 Jul 20. Exp Eye Res. 2017. PMID: 27450911 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical